Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro

Thouverey, Cyril; Caverzasio, Joseph

doi:10.1038/bonekey.2015.126

Scientific article

English

Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro

ContributorsThouverey, Cyril; Caverzasio, Joseph

Published inBoneKEy reports, vol. 4, no. Art. 757

Publication date2015

UNIGE affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

UNIGE research groups

Citation (ISO format)

THOUVEREY, Cyril, CAVERZASIO, Joseph. Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro. In: BoneKEy reports, 2015, vol. 4, n° Art. 757. doi: 10.1038/bonekey.2015.126

Article (Published version)

Identifiers

PID : unige:81123
DOI : 10.1038/bonekey.2015.126

Journal ISSN2047-6396

479views

7downloads

Creation15/01/2016 09:55:00

First validation15/01/2016 09:55:00

Update15/03/2023 00:10:22

Status update15/03/2023 00:10:22

Last indexation31/10/2024 02:51:32

Archive ouverte UNIGE

Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro

Technical informations